Price...

 

The Grass is usually greener on the other side of the fence. Here is the Unifier with his divided party.

Stray...

 

Trillions...

 

Balance...

 

Time to watch the Democrats fighting for wasteful spending.

Debt....

 

NYC

 

Sinema...

 

Personnel...

New York Governor Kathy Hochul is considering employing the National Guard and out-of-state medical workers to fill hospital staffing shortages with tens of thousands of workers possibly losing their jobs for not meeting a Monday deadline for mandated COVID-19 vaccination.  

Hochul said the state was also looking at using National Guard officers with medical training to keep hospitals and other medical facilities adequately staffed. Some 16% of the state's 450,000 hospital staff, or roughly 72,000 workers, have not been fully vaccinated, the governor's office said.  

This is the worse thing that can be done in this case. It is also non practical, labor busting and a disgrace after these employees are the only ones who carried the load of this epedemic where no PPEs no vaccines and no help. Just a disgrace.

Kabul..

 

Molnupiravir

 

 In a potential leap forward in the global fight against the pandemic, drugmaker Merck said that its experimental pill for people sick with COVID-19 reduced hospitalizations and deaths by half.

All other COVID-19 treatments now authorized in the U.S. require an IV or injection. A pill taken at home, by contrast, would ease pressure on hospitals and could also help curb outbreaks in poorer and more remote corners of the world that don’t have access to the more expensive infusion therapies.

Merck and its partner Ridgeback Biotherapeutics said early results showed patients who received the drug, molnupiravir, within five days of COVID-19 symptoms had about half the rate of hospitalization and death.

The study tracked 775 adults with mild-to-moderate COVID-19 who were considered high risk for severe disease because of health problems such as obesity, diabetes or heart disease. The results have not been reviewed by outside experts, the usual procedure for vetting new medical research.